India, Oct. 9 -- Cancer treatment in India can be expensive, with patients often bearing a significant share of medical costs. High medicine prices and mark-ups across the supply chain have raised concerns about affordability, prompting the government to introduce measures aimed at reducing the cost of essential cancer medicines.

Cancer Treatment Stocks: The Centre's decision to cap trade margins on anti-cancer drugs could affect hospital chains such as Max Healthcare, Fortis Healthcare and Apollo Hospitals Enterprise. However, Goldman Sachs noted that oncology medicines account for less than 5 percent of hospital revenue and less than 2 to 2.5 percent of EBITDA, limiting the overall impact.

According to Goldman Sachs, Max Healthcare a...